AB Initio
Ab Initio provides protein-based therapeutics for neurological, cardiovascular, endocrine and gastrointestinal disorders.
Business Model:
Revenue: $6M
Employees: 1-10
Rankings
Industries / Tags:
Detailed AB Initio Information
AB Initio was acquired by
Ligand Pharmaceuticals.
The acquisition happend on 2019-07-23.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 3911 Sorrento Valley Boulevard
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Ab Initio provides protein-based therapeutics for neurological, cardiovascular, endocrine and gastrointestinal disorders.
Contact Phone:
+18585507500
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
